| Financial Year |
March 31 2023 |
| Monetary Funds |
387,506,289.62 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
810,000.00 |
| Accounts Receivable |
1,945,969,316.25 |
| Advances to Suppliers |
126,105,003.63 |
| Other Receivables |
352,537,095.38 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
39,272,429.03 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
645,330,816.92 |
| Other Current Assets |
15,900,183.09 |
| Total Current Assets |
3,737,621,527.06 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
3,309,211,751.57 |
| Long-term Equity Investment |
119,136,996.53 |
| Investment Properties |
9,177,886.84 |
| Fixed Assetes |
304,923,257.60 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
46,963,879.46 |
| R&D expenses |
-- |
| Goodwill |
7,048,201.86 |
| Long-Term Deferred and Prepaid Expenses |
3,085,262.54 |
| Deferred Income Tax Assets |
136,684,939.64 |
| Other Non-Current Assets |
218,294,882.45 |
| Sub-Total of Non-Current Assets |
4,240,741,669.95 |
| Total Assets |
7,978,363,197.01 |
| Short-Term Loans |
669,339,221.13 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
1,611,947,256.82 |
| Accounts Received In Advance |
5,050,748.33 |
| Employee Compensation Payable |
35,660,125.96 |
| Taxes Payable |
335,344,605.72 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
759,297,806.47 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
96,074,984.59 |
| Other Current Liabilities |
11,399,923.11 |
| Sub-Total of Current Liabilities |
3,711,583,663.61 |
| Long-term Loans |
355,639,382.80 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
15,325,293.62 |
| Deferred Income Tax Liabilities |
2,718,721.87 |
| Other Non-Current Liabilities |
4,802.61 |
| Sub-Total of Non-Current Liabilities |
374,033,569.34 |
| Total Liabilities |
4,085,617,232.95 |
| Paid-In Capital(Or Share Stock) |
1,144,223,714.00 |
| Capital Surplus |
4,258,616,780.91 |
| Surplus Reserve |
79,728,979.18 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-1,756,800,029.62 |
| Minority Stockholder's Interest |
98,196,108.11 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,794,549,855.95 |
| Owner's Equity（Stockholder's Equity） |
3,892,745,964.06 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
7,978,363,197.01 |
